| 1 |
Collins J, Epstein JI. Prognostic significance of extensive necrosis in renal cell carcinoma[J]. Hum Pathol, 2017, 66:108-114.
|
| 2 |
Stone L. Kidney cancer: Activation of oncogenes driven by VHL loss in ccRCC[J]. Nat Rev Urol, 2017, 14(11):637.
|
| 3 |
Aleksandrova K, Bamia C, Drogan D, et al. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition[J]. Am J Clin Nutr, 2015, 102(6):1498-1508.
|
| 4 |
Di Gioia D, Stieber P, Schmidt GP, et al. Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase[J]. Br J Cancer, 2015, 112(5):809-818.
|
| 5 |
Robles AI, Harris CC. Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer[J]. Lung Cancer, 2017, 107:50-58.
|
| 6 |
Bernardo BC, Ooi JY, Lin RC, et al. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart[J]. Future Med Chem, 2015, 7(13):1771-1792.
|
| 7 |
Chakraborty C, Chin KY, Das S. miRNA-regulated cancer stem cells: understanding the property and the role of miRNA in carcinogenesis[J]. Tumour Biol, 2016, 37(10):13039-13048.
|
| 8 |
Mcguire A, Brown JA, Kerin MJ. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring[J]. Cancer Metastasis Rev, 2015, 34(1):145-155.
|
| 9 |
Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer[J]. World J Gastroenterol, 2014, 20(30):10432-10439.
|
| 10 |
Ishimoto T, Sugihara H, Watanabe M, et al. Macrophage-derived reactive Oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation[J]. Carcinogenesis, 2014, 35(5):1003-1011.
|
| 11 |
Shi M, Cui J, Xie K. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy[J]. Curr Drug Targets, 2013, 14(10):1192-1202.
|
| 12 |
Maachani UB, Tandle A, Shankavaram U, et al. Modulation of miR-21 signaling by MPS1 in human glioblastoma[J]. Oncotarget, 2016, 7(33):52912-52927.
|
| 13 |
Kong W, He L, Richards EJ, et al. Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer[J]. Oncogene, 2014, 33(6):679-689.
|
| 14 |
Cao J, Liu J, Xu R, et al. MicroRNA-21 stimulates epithelial-to-mesenchymal transition and tumorigenesis in clear cell renal cells[J]. Mol Med Rep, 2016, 13(1):75-82.
|
| 15 |
Gao Y, Ma X, Yao Y, et al. miR-155 regulates the proliferation and invasion of clear cell renal cell carcinoma cells by targeting E2F2[J]. Oncotarget, 2016, 7(15):20324-20337.
|
| 16 |
Butz H, Nofech-Mozes R, Ding Q, et al. Exosomal MicroRNAs are diagnostic biomarkers and can mediate Cell-Cell communication in renal cell carcinoma[J]. Eur Urol Focus, 2016, 2(2):210-218.
|
| 17 |
Li HL, Han L, Chen HR, et al. PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription [J]. Oncotarget, 2015, 6(25):21406-21420.
|
| 18 |
Sato Y, Yoshizato T, Shiraishi Y, et al. Integrated molecular analysis of clear-cell renal cell carcinoma[J]. Nat Genet, 2013, 45(8):860-U191.
|
| 19 |
Araújo WF, Naves MA, Ravanini JN, et al. Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice[J]. Urol Oncol, 2015, 33(9):389.e1-389.e7.
|
| 20 |
Ch'ng WC, Abd-Aziz N, Ong MH, et al. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway[J]. Cell Oncol (Dordr), 2015, 38(4):279-288.
|
| 21 |
Mikami S, Mizuno R, Kosaka T, et al. Expression of TNF-alpha and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas[J]. Int J Cancer, 2015, 136(7):1504-1514.
|
| 22 |
Guin S, Theodorescu D. The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer[J]. Acta Pharmacol Sin, 2015, 36(3):291-297.
|
| 23 |
Xia P, Zhang R, Ge G. C/EBPβ mediates TNF-α-Induced cancer cell migration by inducing MMP expression dependent on p38 MAPK[J]. J Cell Biochem, 2015, 116(12):2766-2777.
|
| 24 |
Zhang X, Ma L, Qi J, et al. MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy[J]. Mol Cell Biochem, 2015, 410(1/2):101-110.
|